Danvatirsen

Overview

Danvatirsen is a STAT3 targeting antisense oligonucleotide inhibitor that is being studied for use in several different kinds of cancer. 

SparkCures ID 719
Generic Name Danvatirsen
Additional Names AZD9150
Treatment Classifications
  • Antisense Oligonucleotide (ASO)

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.